Phase II multicenter study of neoadjuvant chemotherapy with XELOX for locally advanced rectal cancer
Phase 2
- Conditions
- Stage II or III rectal cancer
- Registration Number
- JPRN-UMIN000024357
- Lead Sponsor
- Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
Not provided
Exclusion Criteria
1. With distant metastasis (M1) 2. Cancerous fluid 3. Active infectious disease 4. Concomitant malignancy (within 5 years) and double cancer 5. Uncontrolled diabetic 6. Peripheral neuropathy 7. Serious lung disease 8. Clinically significant cardiac disease 9. Pregnant women and nursing mothers, possibly pregnant women, and men attempting to conceive a child 10. Other conditions judged ineligible by physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method